Iron deficiency signals danger to our immune cells and leads to excessive immune responses. At the same time, a hyperactive immune system also inhibits the absorption of the micronutrient iron. This creates a vicious circle that triggers allergic reactions.
A research team from the Messerli Research Institute at MedUni Vienna, Vetmeduni Vienna and the University of Vienna has now demonstrated for the first time that a targeted dietary intervention can reduce the burden of symptoms associated with allergic reactions.
To compensate for the deficiency in immune cells, the research team developed a lozenge, which was tested for the first time in a double-blind, placebo-controlled trial as part of the study.
The lozenge is based on the cow’s whey protein beta-lactoglobulin, which acts as a carrier for numerous micronutrients. “Thanks to this carrier, absorption takes place via the lymph rather than through the blood vessels – in other words, precisely where immune cells are found in greater numbers and can specifically absorb the micronutrients,” explains study leader Franziska Roth-Walter. As one lozenge contains less than one milligram – a very small amount of iron – it is not classified as an iron supplement. Rather, the micronutrient is present in a form that allows the allergy-induced inhibition of iron absorption to be bypassed. According to the study results, taking this lozenge significantly reduced the symptom burden associated with birch and grass pollen allergies. Furthermore, iron status in circulating monocytes and red blood cell counts improved. After six months of taking the lozenge in combination with the necessary medication (‘Combined Symptom Medication Score’), a 45 per cent reduction in symptoms was achieved in patients during the peak birch pollen season.
To date, specific allergen immunotherapy has been regarded as the only causal treatment option for alleviating allergic conditions. “Supplying the immune cells with micronutrients via the lozenge demonstrated a similarly high level of efficacy, and did so in a manner that is completely allergen-independent and therefore universal,” explains Roth-Walter. The researchers are thus breaking new ground. The study was recently published in *The Journal of Allergy and Clinical Immunology: In Practice*.
Reference:
Messerli Research Institute of MedUni Vienna, Vetmeduni Vienna and the University of Vienna
Bartosik T et al., The Journal of Allergy and Clinical Immunology: In Practice Ameliorating Atopy by Compensating Micronutritional Deficiencies in Immune Cells: a Double-Blind Placebo-Controlled Pilot Study
https://doi.org/10.1016/j.jaip.2022.02.028
#allergy #pollenallergy #birchpollen #grasspollen #irondeficiency #wheyprotein #immunesystem #medicine #allergology